A quantitative real-time PCR high resolution melting (HRM) method for evaluating the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in malignant gliomas is superior to conventional methylation specific PCR in predicting clinical outcome and survival in patients with malignant glioma
Autor: | Switzeny, Olivier J., Renovanz, Mirjam, Sommer, Clemens, Christmann, Markus, Giese, Alf, Kaina, Bernd |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: | |
Zdroj: | 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC); 20150607-20150610; Karlsruhe; DOCP 040 /20150602/ |
DOI: | 10.3205/15dgnc438 |
Popis: | Objective: MGMT promoter status is an important prognostic factor in high-grade glioma patients and indispensable for decision making in neurooncological therapy. Currently, the MGMT promoter methylation is determined by methylation-specific PCR (MSP). The development of new approaches to improving [for full text, please go to the a.m. URL] 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) |
Databáze: | OpenAIRE |
Externí odkaz: |